EPO-TBI is a trial of EPO as cerebral protection after traumatic brain injury, and the renal substudy assesses the effect of EPO on the development of acute kidney injury (AKI) and the response to treatment using multiple renal biomarkers with different time profiles in patients with traumatic brain injury. The gene discussed is EPO; the disease is acute kidney injury.